TORONTO DOMINION BANK - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$806
+80500.0%
90.0%0.00%
Q2 2023$1
-100.0%
9
-99.9%
0.00%
-100.0%
Q1 2022$480,0007,600
+253233.3%
0.00%
Q4 2021$0
-100.0%
3
-99.0%
0.00%
Q4 2020$36,000
+38.5%
3000.0%0.00%
Q3 2020$26,000
-3.7%
3000.0%0.00%
Q2 2020$27,0003000.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders